<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Choice of adjuvant systemic therapy in hormone receptor-positive, HER2-negative early breast cancer that is node negative</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Choice of adjuvant systemic therapy in hormone receptor-positive, HER2-negative early breast cancer that is node negative</h1>
<div class="graphic"><div class="figure"><div class="ttl">Choice of adjuvant systemic therapy in hormone receptor-positive, HER2-negative early breast cancer that is node negative</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes"><p>HER2: human epidermal growth factor receptor 2; RS: recurrence score.</p>
<p>* Using a gene expression profile to guide chemotherapy decisions is only appropriate in patients who are appropriate candidates for chemotherapy. Candidacy for chemotherapy is determined by baseline health status.</p>
<p>¶ Other gene expression profiles are available as well, including PAM50, Mammaprint, Endopredict, and the Breast Cancer Index.</p>
<p>Δ Data supporting chemotherapy for RS 25 to 30 are less clear than for RS &gt;30. Refer to UpToDate topic on deciding when to use chemotherapy in hormone receptor-positive, HER2-negative breast cancer for further details.</p>
<span class="lozenge">◊</span> TAILORx suggested that in women ≤50 years and with an intermediate RS, chemotherapy plus endocrine therapy was associated with a lower rate of distant recurrence relative to endocrine therapy alone, particularly for those with high-intermediate scores (21 to 25) or clinical risk features. However, this was based only on exploratory subset analyses, and moreover, some of the benefit hypothetically may have been due to ovarian suppression in premenopausal women. Ovarian suppression was not assessed as a treatment strategy in this trial, however. In light of limitations in the data, either chemotherapy and endocrine therapy, or endocrine therapy only (with ovarian suppression in premenopausal women) are acceptable options. Refer to UpToDate topic on deciding when to use chemotherapy in hormone receptor-positive, HER2-negative breast cancer for further details.</div><div id="graphicVersion">Graphic 131640 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
